National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

antineoplaston A10
A piperidinedione antineoplaston with potential antineoplastic activity. Antineoplaston A10 was originally isolated from human urine but is now synthetically derived. This agent intercalates into DNA, resulting in cell cycle arrest in G1 phase, reduction of mitosis, and decreased protein synthesis. Antineoplaston A10 may also inhibit ras-oncogene expression and activate tumor suppressor gene p53, leading to cell differentiation and apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:A10
Chemical structure name:3-phenylacetylamino-2, 6-piperidinedione



Previous:anti-PD-L1 monoclonal antibody MDX-1105, anti-PLGF monoclonal antibody TB-403, anti-PSCA fully human monoclonal antibody MK4721, anti-thymocyte globulin, antibody-drug conjugate CR011-vcMMAE
Next:antineoplaston AS2-1, Antrin, Anzemet, apatinib, apaziquone

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov